Overview
Understanding Eisai integration
Who this is for: Wholesalers, distributors, pharmacies, hospitals and suppliers that trade with Eisai, and their purchasing, contract and finance teams.
Scope: This guide describes typical practice for this kind of trading relationship; Eisai's own program details are confirmed during onboarding.
Eisai is a Japanese pharmaceutical company, with US operations in Nutley, New Jersey, focused on neurology and oncology medicines. ECOM's directory lists Eisai under pharmaceutical manufacturing.
Like most pharmaceutical makers it sells through wholesalers and specialty distributors, so orders, shipment notices, invoices, resale and chargeback data are the typical exchange points with trading partners. A pharmaceutical manufacturer typically sells through wholesalers and specialty distributors rather than directly to every pharmacy, so the main documents are orders and shipment notices from the wholesaler side, plus resale (867), inventory and chargeback (844) reporting. Direct accounts, such as hospitals or large chains, add invoices and remittance. DSCSA serialization data travels with product as a supply program requirement. The document set below is typical practice for this type of company; confirm the documents, X12 version, delivery method and testing steps with Eisai for your own program.
ECOM helps confirm your trading program, map the required documents, configure connectivity, and complete testing against the applicable specifications. It then monitors every file after go-live and handles partner changes, as software, as a managed service or both.